Palvella Therapeutics
Latest funding:$200.0M · Post-IPO Equity (February 25, 2026)
Angel investors who backed Palvella Therapeutics
14 investors in our database backed Palvella Therapeutics.
Kelly Meldrum
Partner and Head of Primary Funds
Adams Street Partners
Eric Mansell
Partner, Chief Legal Officer
Adams Street Partners
Frederick (Rick) Jones
Partner
Shahram Hejazi
Managing Director & CEO (Oct. 2021)
Marnie McCoy
Program Director
BioAdvance Capital
Robert Driscoll
Director of Finance
Barbara Schilberg
Managing Director and CEO
Geeta Vemuri
Founder and Managing Partner
Agent Capital
Preston Noon
General Partner, Co-Founder
Agent Capital
Rob Weitz
Managing Director
Nolan Capital, Inc.
Jake Ksendzov
Associate
Paras Mehta
CIO
Peter Nolan
Chairman
Cory Freedland
Partner
Who invested in...
See every angel investor and VC behind well-known startups.
Find the right investors for your startup
Search thousands of angel investors and VCs by industry, stage, check size, and location — and see who backed companies like Palvella Therapeutics.
Search investors